As of 2025-12-12, the Relative Valuation of Eli Lilly and Co (LLY) is 372.79 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1,009.38 USD, the upside of Eli Lilly and Co based on Relative Valuation is -63.1%.
The range of the Relative Valuation is 251.95 - 581.94 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 29.9x | 24.7x |
| Forward P/E multiples | 18.6x - 20.1x | 19.6x |
| Fair Price | 251.95 - 581.94 | 372.79 |
| Upside | -75.0% - -42.3% | -63.1% |
| Date | P/E |
| 2025-12-11 | 51.83 |
| 2025-12-10 | 51.02 |
| 2025-12-09 | 50.43 |
| 2025-12-08 | 51.22 |
| 2025-12-05 | 51.87 |
| 2025-12-04 | 52.09 |
| 2025-12-03 | 53.07 |
| 2025-12-02 | 53.71 |
| 2025-12-01 | 54.32 |
| 2025-11-28 | 55.22 |
| 2025-11-26 | 56.70 |
| 2025-11-25 | 56.99 |
| 2025-11-24 | 54.95 |
| 2025-11-21 | 54.41 |
| 2025-11-20 | 53.57 |
| 2025-11-19 | 53.89 |
| 2025-11-18 | 52.89 |
| 2025-11-17 | 52.46 |
| 2025-11-14 | 52.64 |
| 2025-11-13 | 52.52 |
| 2025-11-12 | 52.26 |
| 2025-11-11 | 50.76 |
| 2025-11-10 | 49.63 |
| 2025-11-07 | 47.46 |
| 2025-11-06 | 48.13 |
| 2025-11-05 | 47.54 |
| 2025-11-04 | 46.56 |
| 2025-11-03 | 46.03 |
| 2025-10-31 | 44.30 |
| 2025-10-30 | 43.36 |
| 2025-10-29 | 41.77 |
| 2025-10-28 | 42.11 |
| 2025-10-27 | 42.43 |
| 2025-10-24 | 42.38 |
| 2025-10-23 | 42.16 |
| 2025-10-22 | 41.71 |
| 2025-10-21 | 41.05 |
| 2025-10-20 | 41.54 |
| 2025-10-17 | 41.22 |
| 2025-10-16 | 42.07 |
| 2025-10-15 | 42.44 |
| 2025-10-14 | 41.71 |
| 2025-10-13 | 42.07 |
| 2025-10-10 | 42.80 |
| 2025-10-09 | 43.92 |
| 2025-10-08 | 43.42 |
| 2025-10-07 | 43.32 |
| 2025-10-06 | 43.39 |
| 2025-10-03 | 43.12 |
| 2025-10-02 | 42.10 |